Luis Wehbe
Publications by Year
Research Areas
Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, Eosinophilic Disorders and Syndromes, Respiratory Support and Mechanisms, Obesity, Physical Activity, Diet
Most-Cited Works
- → INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD(2014)121 cited
- → Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial(2018)67 cited
- → Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study(2021)42 cited
- → Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19(2023)31 cited
- → Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5(2022)20 cited
- → Progressive nicotine patch dosing prior to quitting smoking: feasibility, safety and effects during the pre‐quit and post‐quit periods(2018)14 cited
- → Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study(2023)14 cited
- → Want, need and habit as drivers of smoking behaviour: A preliminary analysis(2017)8 cited
- [Chronic eosinophilic pneumonia].(2012)
- → Salmeterol/fluticasone combination instead of indacaterol orvice-versa?(2015)1 cited